World-first clinical trial to help millions of people with penicillin allergies
The PALACE study, an international research endeavour, has evaluated a safer and simpler approach to penicillin allergy testing
RI-MUHC trainee honoured by the Canadian Association for HIV Research
Wesal Elgretli’s M.Sc. project underlines the importance of addressing liver disease simultaneously with HCV infection
IDIGH Program gathers at the Glen site for seventh annual research day
Researchers and trainees from the Infectious Diseases and Immunity in Global Health Program at the RI-MUHC enjoyed a stimulating day...
Getting things started at the McGill Antimicrobial Resistance Centre
RI-MUHC and McGill researchers join forces against a major global threat to human health
MedSafer wins First Jury Prize in Acfas Génies en affaires competition
Designed by MUHC clinicians and researchers, MedSafer is an application that helps reduce drug prescriptions...
Five RI-MUHC researchers receive new funding from MI4
Innovative approaches in addressing pandemic threats, antimicrobial resistance, and the microbes that shape human health were supported in...
Equitable diagnosis for chlamydia and gonorrhea screening worldwide is the aim of one RI-MUHC trainee
Fio Vialard’s publication in BMJ Sexually Transmitted Infections will help policymakers customize...
Bertrand Lebouché wins the CAHR-CANFAR Excellence in Research Award
Deeply committed to outreach, Dr. Lebouché is being recognized for conducting patient-oriented...
Picture a Scientist: the RI-MUHC marks International Women’s Day with film screening and discussion
A panel of RI-MUHC women scientists and allies discuss the roles of women in science
McGill medical student presents her RI-MUHC research project at CROI 2023
Dana Kablawi is investigating sex differences in the association of HIV with metabolic-fatty liver disease